BNT162b2 COVID-19 and ChAdOx1 nCoV-19 vaccination in patients with myelodysplastic syndromes. (2022)
Attributed to:
Evaluation of the CD4+ T cell tumour microenvironment of low grade B cell lymphoproliferative disorders
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3324/haematol.2021.280337
PubMed Identifier: 35045695
Publication URI: http://europepmc.org/abstract/MED/35045695
Type: Journal Article/Review
Volume: 107
Parent Publication: Haematologica
Issue: 5
ISSN: 0390-6078